Kidney Transplant Clinical Trials

Clinical trials related to Kidney Transplant Procedure

Vascular Complications After Kidney Transplantation: A Prospective National Multicenter Study - The DAN-PTRAIII Study

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test, Procedure
Study Type: Observational
SUMMARY

* To determine the incidence of arterial inflow problems and venous outflow problems as causes of impaired renal function and/or treatment-resistant hypertension after kidney transplantation, when all kidney-transplant recipients in Denmark are evaluated according to uniform, well-defined clinical criteria. * To investigate the efficacy and safety of catheter-based balloon treatment (percutaneous transluminal angioplasty, PTA) for these vascular complications, of which transplant renal artery stenosis is by far the most common. * To assess whether novel imaging and functional diagnostic methods can predict treatment response.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 1\. At least one of the following clinical criteria (1 or 2) must be fulfilled:

• Graft dysfunction, defined by at least one of the following:

‣ Acute reduction in estimated glomerular filtration rate (eGFR) \>15% on two consecutive measurements at least 2 weeks apart, with other causes excluded (rejection, obstruction, infection).

⁃ eGFR \<50% of the expected value 30 days after kidney transplantation of unknown cause.

⁃ Decline in eGFR \>30% after initiation of an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker.

• Persistent resistant hypertension for more than 6 weeks after kidney transplantation, defined as:

‣ 24-hour ambulatory systolic blood pressure \>130 mmHg despite treatment with at least three classes of antihypertensive medication at maximally tolerated doses (including diuretics, if tolerated).

• Together with at least one of the following radiological criteria:

• CT or MR angiography demonstrating a lumen reduction ≥50%.

• Doppler ultrasound showing:

∙ Peak systolic velocity in the renal artery ≥200 cm/s and a renal renal ratio (velocity at stenosis / velocity in distal artery) \>4.

‣ Acceleration time \>70 ms in intrarenal arteries.

• 2\. In cases of strong clinical suspicion of a vascular complication where CT or MR angiography cannot reliably exclude graft artery or vein stenosis, patients may be referred for confirmatory invasive investigations.

• Before PTA, catheter-based angiography and translesional pressure measurements are performed to confirm whether the patient meets the radiological eligibility criterion for PTA:

• Stenosis ≥70%.

• Stenosis 50-69% if at least one of the following criteria is met:

‣ Mean translesional pressure gradient ≥10 mmHg.

⁃ Systolic pressure gradient ≥20 mmHg.

⁃ Renal Pd/Pa ≤0.8.

⁃ If pressure measurements cannot be obtained, treatment is based on the operator's clinical judgement.

Locations
Other Locations
Denmark
Aarhus University Hospital
RECRUITING
Aarhus
Rigshospitalet
RECRUITING
Copenhagen
Odense University Hospital
RECRUITING
Odense
Contact Information
Primary
Mark Reinhard, MD, PhD
markrein@rm.dk
+45 40460321
Backup
Henrik Birn, MD, DMSc
hb@clin.au.dk
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2031-03-31
Participants
Target number of participants: 60
Treatments
Kidney Transplant Recipients
Patients who meet well-defined clinical and radiological criteria for significant vascular complications after kidney transplantation, with transplant renal artery stenosis being by far the most common.
Sponsors
Collaborators: Gødstrup Hospital, Odense University Hospital, Amsterdam UMC, Aalborg University Hospital, The Augustinus Foundation, Denmark., Holbaek Sygehus, Aarhus University Hospital, Rigshospitalet, Denmark
Leads: University of Aarhus

This content was sourced from clinicaltrials.gov